Análise da preferência digital de idade no sistema de farmacovigilância do Brasil, 2008-2013

by Daniel Marques Mota, Álvaro Vigo, Ricardo de Souza Kuchenbecker

Deriving meaningful insights from clinical trial and postmarketing safety data: Perspectives from India

by Anand Harugeri, Vineet Shastri, Chanakya Patel
Published 2017-01-01

Safety Profile of Anticancer and Immune-Modulating Biotech Drugs Used in a Real World Setting in Campania Region (Italy): BIO-Cam Observational Study

by Cristina Scavone, Liberata Sportiello, Maria G. Sullo, Carmen Ferrajolo, Rosanna Ruggiero, Maurizio Sessa, Pasquale M. Berrino, Gabriella di Mauro, Liberato Berrino, Francesco Rossi, Concetta Rafaniello, Annalisa Capuano, BIO-Cam Group, G. Valentini, M. Romano, A. Lo Schiavo, F. Morgillo, R. Nuzzetti, R. D'Aniello, M. L. Aiezza, E. Bizzarro, A. Dello Stritto, G. Di Renzo, V. Trimarco, V. Valente, M. G. Lombardi, M. Spatarella
Published 2017-09-01

Trends analysis for drug utilization in county public hospitals: a sample study of the pilot area of health care reform in China

by Xuefeng Xie, Xu Jin, Ling Zhang, Huihui Sun, Aizong Shen, Xiaohui Huang, Yehuan Sun
Published 2018-10-01

Incidence of adverse drug reactions in human immune deficiency virus-positive patients using highly active antiretroviral therapy

by B Akshaya Srikanth, S Chandra Babu, Harlokesh Narayan Yadav, Sunil Kumar Jain
Published 2012-01-01

Campania Preventability Assessment Committee (Italy): A Focus on the Preventability of Non-steroidal Anti-inflammatory Drugs' Adverse Drug Reactions

by Maurizio Sessa, Liberata Sportiello, Annamaria Mascolo, Cristina Scavone, Silvia Gallipoli, Gabriella di Mauro, Daniela Cimmaruta, Concetta Rafaniello, Annalisa Capuano
Published 2017-05-01

An evaluation of knowledge, attitude, and practice of institutional ethics committee members from eastern India regarding ethics committee functioning and pharmacovigilance activities conducted during...

by Subhrojyoti Bhowmick, Koyel Banerjee, Shreya Sikdar, Tapan Kumar Chatterjee
Published 2014-01-01

Using the theory of planned behavior to predict Texas pharmacists' intention to report serious adverse drug events

by Gavaza, Paul, 1972-
Published 2010

Use of trigger tool to identify Adverse Drugs Events in dogs.

by Beatriz Cristina de Oliveira Fonseca, Marcela Forgerini, Leila Crystina Dias Zorzin, Marcelo Rodrigues Martins, Patrícia de Carvalho Matroianni, Angela Ferreira Lopes, Paulo Henrique Jorge da Cunha, Nathalie de Lourdes Souza Dewulf
Published 2020-12-01

Perceptions and experiences of reporting of adverse drug reactions by public sector pharmacists in a rural district in the Western Cape

by Williams, Charles
Published 2016

Perfil de prescrição de medicamentos e interações medicamentosas em pacientes acima de 60 anos atendidos em hospital universitário: uma contribuição à farmacovigilância

by Andre Luiz Salim Novato
Published 2005

AvaliaÃÃo da farmacovigilÃncia na quimioterapia antineoplÃsica com o protocolo FEC (5-fluorouracil, epirrubicina e ciclofosfamida) em pacientes com cÃncer de mama.

by Ana Herminia Portela Bandeira de Melo FalcÃo
Published 2009

Perfil de prescrição de medicamentos e interações medicamentosas em pacientes acima de 60 anos atendidos em hospital universitário: uma contribuição à farmacovigilância

by Novato, Andre Luiz Salim
Published 2005

Similarity-based machine learning framework for predicting safety signals of adverse drug–drug interactions

by Heba Ibrahim, Ahmed M. El Kerdawy, A. Abdo, A. Sharaf Eldin
Published 2021-01-01

The Perception of Primary School Teachers Regarding the Pharmacotherapy of Attention Deficit Hyperactivity Disorder

by João Gregório, Raquel Ferreira, Ana Sofia Fernandes
Published 2021-06-01

Bioinformatics Accelerates the Major Tetrad: A Real Boost for the Pharmaceutical Industry

by Tapan Behl, Ishnoor Kaur, Aayush Sehgal, Sukhbir Singh, Saurabh Bhatia, Ahmed Al-Harrasi, Gokhan Zengin, Elena Emilia Babes, Ciprian Brisc, Manuela Stoicescu, Mirela Marioara Toma, Cristian Sava, Simona Gabriela Bungau
Published 2021-06-01

Mortality Rate and Characteristics of Deaths Following COVID-19 Vaccination

by Gang Lv, Jing Yuan, Xiaomo Xiong, Minghui Li
Published 2021-05-01

Chimeric Antigen Receptor T Cell Therapy Management and Safety: A Practical Tool From a Multidisciplinary Team Perspective

by María Belen Marzal-Alfaro, Vicente Escudero-Vilaplana, Jose Luis Revuelta-Herrero, Roberto Collado-Borrell, Ana Herranz-Alonso, Maria Sanjurjo-Saez
Published 2021-03-01

Les enjeux de sécurité de la prescription hors AMM : l’exemple du baclofène dans l’alcoolodépendance

by Auffret, Marine
Published 2017

Severe cutaneous adverse drug reactions manifesting as Stevens-Johnson syndrome and toxic epidermal necrolysis reported to the national pharmacovigilance center in Nigeria: a database review from 2004 to 2017

by Kazeem Adeola Oshikoya, Ibrahim Abayomi Ogunyinka, Comfort Kunak Ogar, Abiodun Abiola, Ali Ibrahim, Ibrahim Adekunle Oreagba
Published 2020-02-01